| Literature DB >> 27640026 |
Lennart van Gils1, Didier Tchetche, Azeem Latib, Carmelo Sgroi, Ganesh Manoharan, Helge Möllmann, Nicolas M Van Mieghem.
Abstract
Transcatheter aortic valve implantation (TAVI) has evolved from an exclusive, highly complex and hazardous procedure into a mature, safe and streamlined therapy for patients with severe aortic stenosis (AS). Various successive device iterations and product refinements have created a dynamic and competitive field with a spectrum of different CE-marked transcatheter heart valve (THV) designs. This review provides a practical overview of current CE-marked THVs with a focus on respective sizing algorithms and delivery strategies.Entities:
Mesh:
Year: 2016 PMID: 27640026 DOI: 10.4244/EIJV12SYA6
Source DB: PubMed Journal: EuroIntervention ISSN: 1774-024X Impact factor: 6.534